Department of General Thoracic Surgery, Saiseikai Utsunomiya Hospital, Tochigi, Japan.
Department of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, Japan; Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Clin Lung Cancer. 2021 Nov;22(6):e820-e828. doi: 10.1016/j.cllc.2021.04.001. Epub 2021 Apr 18.
Histologic subtyping offers some prognostic value in lung adenocarcinoma. We thus hypothesized that histologic subtypes may be useful for risk stratification of brain metastasis (BM). In this study, we aimed to investigate the impact of histologic subtypes on the risk for BM in patients with resected lung adenocarcinoma.
Of 1099 consecutive patients who had undergone curative-intent surgery (2000-2014), 448 patients who had undergone complete resection for lung adenocarcinoma were included in this study. Correlated clinical variables and BM-free survival were analyzed.
Micropapillary predominance was significantly associated with higher risk of BM after complete resection in univariate analyses (P < .001). In addition, multivariate analyses showed that micropapillary predominance was an independent risk factor for BM (hazard ratio = 2.727; 95% confidence interval, 1.260-5.900; P = .011), along with younger age and advanced pathologic stage. Unlike the other subtypes, an increase in the percentage of the micropapillary subtype was positively correlated with an increase in BM frequency. Patients with micropapillary adenocarcinoma showed significantly poorer brain metastasis-free survival compared with those with non-micropapillary adenocarcinoma (3 years, 78.2% vs. 95.6%; 5 years, 67.3% vs. 94.3%; P < .001).
The current study demonstrated a significant correlation between micropapillary subtype and higher risk of BM in patients with resected lung adenocarcinoma. This routine histologic evaluation of resected adenocarcinoma may provide useful information for the clinician when considering postoperative management in patients with lung adenocarcinoma. Histologic subtyping offer some prognostic value in lung adenocarcinoma. Because brain metastasis is critical and often refractory to systemic chemotherapy, early detection is clinically important to achieve effective local treatment. We retrospectively analyzed the association between histologic subtypes and occurrence of brain metastasis and found a significant association between micropapillary predominance and higher risk for brain metastasis. Our findings may be relevant when considering postoperative management.
组织学亚型在肺腺癌中具有一定的预后价值。因此,我们假设组织学亚型可能有助于肺腺癌脑转移(BM)的风险分层。在这项研究中,我们旨在探讨组织学亚型对接受根治性手术治疗的肺腺癌患者发生 BM 的风险的影响。
在 1099 例连续接受根治性手术(2000-2014 年)的患者中,纳入了 448 例接受肺腺癌完全切除术的患者。分析了相关的临床变量和无 BM 生存情况。
在单因素分析中,微乳头优势与完全切除术后 BM 风险显著相关(P<0.001)。此外,多因素分析显示,微乳头优势是 BM 的独立危险因素(危险比=2.727;95%置信区间,1.260-5.900;P=0.011),此外还与年龄较小和较晚的病理分期有关。与其他亚型不同,微乳头亚型比例的增加与 BM 发生率的增加呈正相关。微乳头腺癌患者的脑转移无复发生存率明显低于非微乳头腺癌患者(3 年,78.2% vs. 95.6%;5 年,67.3% vs. 94.3%;P<0.001)。
本研究表明,在接受肺腺癌根治性手术的患者中,微乳头亚型与 BM 风险较高显著相关。这种对切除的腺癌进行常规组织学评估,在考虑肺腺癌患者的术后管理时,可能为临床医生提供有用的信息。组织学亚型在肺腺癌中具有一定的预后价值。由于脑转移是关键的,且通常对全身化疗有抵抗性,早期检测对实现有效的局部治疗具有重要的临床意义。我们回顾性分析了组织学亚型与脑转移发生之间的关系,发现微乳头优势与较高的脑转移风险显著相关。我们的研究结果在考虑术后管理时可能具有相关性。